GE HealthCare reports second quarter 2024 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
GE HealthCare (GEHC) PT Raised to $92 at Jefferies
July 31, 2024 3:50 PM EDTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $92.00 (from $87.00) while maintaining a Hold rating.
The analyst comments "GEHC reported 2Q24 sales of $4.84B, +1% organic vs cons $4.88B, and EPS of $1.00 (+9%) vs cons $0.98. Orders increased +3%... More
GE HealthCare (GEHC) beats earnings but cuts full-year revenue outlook amid China headwinds
July 31, 2024 6:43 AM EDTGE HealthCare (NASDAQ: GEHC) delivered better-than-expected second-quarter earnings, but the company has tempered its full-year outlook due to headwinds in the Chinese market, sending its shares more than 8% lower in premarket trading.
While the medical technology giant reported adjusted earnings per share (EPS) of $1.00, surpassing analyst estimates by $0.02, revenue came in at $4.84 billion, slightly below expectations of $4.87 billion.
The company attributed the revenue shortfall to... More
